Suppr超能文献

巨噬细胞炎性蛋白-3α/CC趋化因子配体20在中枢神经系统T细胞介导的炎症免疫启动中的作用。

A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.

作者信息

Kohler Rachel E, Caon Adriana C, Willenborg David O, Clark-Lewis Ian, McColl Shaun R

机构信息

Department of Molecular Biosciences, University of Adelaide, Adelaide, South Australia, Australia.

出版信息

J Immunol. 2003 Jun 15;170(12):6298-306. doi: 10.4049/jimmunol.170.12.6298.

Abstract

Chemokines are a family of cytokines that exhibit selective chemoattractant properties for target leukocytes and play a significant role in leukocyte migration. In this study, we have investigated the role of the C-C chemokine, macrophage inflammatory protein (MIP)-3alpha/CC chemokine ligand 20, in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a model of T cell-dependent inflammation. Expression in the CNS of MIP-3alpha, as determined by RT-PCR, increased in a time-dependent manner such that peak expression correlated with peak clinical disease. Similarly, levels of immunoreactive MIP-3alpha in the draining lymph nodes increased up to 10-fold 9 days postimmunization and remained elevated for up to 21 days postimmunization. The increased production of MIP-3alpha coincided with onset of clinical disease. Treatment of mice with specific neutralizing anti-MIP-3alpha Abs significantly reduced the severity of both clinical EAE and neuroinflammation by inhibiting the sensitization of lymphocytes to the specific Ag and release of lymphocytes from the draining lymph nodes. In contrast, adoptive transfer experiments indicated that MIP-3alpha was not essential for the effector phase of EAE. Together, these data demonstrate that MIP-3alpha plays a critical role in the sensitization phase of EAE.

摘要

趋化因子是一类细胞因子,对靶白细胞具有选择性趋化活性,并在白细胞迁移中发挥重要作用。在本研究中,我们研究了C-C趋化因子巨噬细胞炎性蛋白(MIP)-3α/CC趋化因子配体20在实验性自身免疫性脑脊髓炎(EAE)发病机制中的作用,EAE是一种T细胞依赖性炎症模型。通过逆转录聚合酶链反应(RT-PCR)测定,MIP-3α在中枢神经系统中的表达呈时间依赖性增加,峰值表达与临床疾病高峰期相关。同样,引流淋巴结中免疫反应性MIP-3α的水平在免疫后9天增加至10倍,并在免疫后长达21天保持升高。MIP-3α产生的增加与临床疾病的发作同时发生。用特异性中和抗MIP-3α抗体治疗小鼠,通过抑制淋巴细胞对特异性抗原的致敏作用以及淋巴细胞从引流淋巴结的释放,显著降低了临床EAE和神经炎症的严重程度。相比之下,过继转移实验表明MIP-3α对EAE的效应阶段并非必不可少。总之,这些数据表明MIP-3α在EAE的致敏阶段起关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验